more_reports

The Latest Healthcare Services Articles from Streetwise Reports

Nvidia Commits US$1B to American Science Push in Tech, Energy, and Healthcare

  ()
Nvidia Corporation (NVDA:NASDAQ) announced commitments valued at US$1 billion over five years to advance U.S. scientific research and development, including quantum computing, healthcare and energy security, building on its partnerships with national laboratories and the Department of Energy.
Tags: Alternative EnergyTechnologyHealthcare Services

The FDA Clarified Its Rules for Medical AI. This Stock Could Be on the Right Side of Them

  ()
Rocket Doctor AI Inc. (AIDR:CSE; AIRDF:OTCQB; 939:FSE) continues to evolve its physician-led healthcare platform as revised FDA guidance, new state healthcare AI laws, and rising U.S. patient volumes reshape the regulatory and commercial environment.
Tags: Life Sciences Tools & DiagnosticsHealthcare Services

Sernova and Seraxis Bet on BetaNova to Take Diabetes Cell Therapy Into the Clinic

  ()
Sernova Biotherapeutics Inc. (SVA:TSX; SEOVF:OTCQB; PSH0:XETRA) and Seraxis Holdings Inc. are moving toward a merger to form BetaNova Biotherapeutics, with a type 1 diabetes cell therapy trial planned for early 2027. Find out why one analyst says Sernova found the right partner.
Tags: Life Sciences Tools & DiagnosticsBiotechnology / PharmaceuticalsMedical DevicesHealthcare Services

Rocket Doctor AI Delivers 3625 U.S. Patient Visits in July and August

  ()
Rocket Doctor AI reports 3,625 completed U.S. patient visits in the first two months of Q3 2026. The update highlights ongoing U.S. expansion and telehealth momentum for retail investors.
Tags: Healthcare ServicesLife Sciences Tools & Diagnostics

US Patient Visits Reach 93% of Prior Quarter's Total in Two Months

  ()
Rocket Doctor AI Inc. (AIDR:CSE; AIRDF:OTC; 939:FRA) reported 3,625 completed U.S. patient visits in July and August, alongside 1,555 clinical hours as its U.S. operations expanded.
Tags: Healthcare ServicesLife Sciences Tools & Diagnostics

Cleantech Firm Expands Breakthrough Wound Solution to Veterans

  ()
BioLargo Inc. (BLGO:OTCQX) is bringing its FDA-cleared ViaCLYR wound solution to U.S. government and VA-contracted healthcare facilities through a new deal with Spartan Medical.
Tags: TechnologyHealthcare ServicesCleantechSpecial Situations

BioLargo Subsidiary Secures Spartan Medical Deal for ViaCLYR Government Sales

  ()
BioLargo subsidiary Clyra enters an exclusive reseller agreement with Spartan Medical for ViaCLYR wound care solution targeting U.S. government facilities and ECAT listing amid expanding wound care demand.
Tags: TechnologyHealthcare ServicesCleantechSpecial Situations

AI Cancer Drug Pipeline Advances as 72% of Budget Shifts to Drug Discovery

  ()
Rakovina Therapeutics Inc. (RKV:TSX.V) cut its Q2 net loss 41% year over year while advancing three AI-powered cancer drug programs and closing a CA$1.99 million non-brokered private placement after quarter-end.
Tags: Life Sciences Tools & DiagnosticsHealthcare Services

Rakovina Therapeutics Shifts 72% of Budget to AI Cancer Programs

  ()
Rakovina Therapeutics allocated 72% of its budget to AI-powered drug discovery in the second quarter of 2026, up from 57% in Q2 2025. See the three AI-supported DDR programs and upcoming milestones for retail investors.
Tags: Life Sciences Tools & DiagnosticsHealthcare Services

Digital Health Platform Sees US Patient Visits Surge 196% and Quarterly YoY Revenue Jumps 43%

  ()
Rocket Doctor AI Inc. (AIDR:CSE; AIRDF:OTC; 939:FRA) reported Q2 revenue of US$734,028 as U.S. patient visits nearly tripled and its in-network coverage expanded to approximately 24 million lives.
Tags: Life Sciences Tools & DiagnosticsHealthcare Services

Telehealth Platform Delivers 196% U.S. Visit Growth in Q2

  ()
Rocket Doctor AI reports 43% revenue growth and 196% U.S. patient visit increase in Q2 2026, backed by 24 million covered lives and an expanding payer network.
Tags: Life Sciences Tools & DiagnosticsHealthcare Services

Cleantech Firm Raises 86% of Capital Without Selling Stock

  ()
Cleantech innovator BioLargo Inc. (BLGO:OTCQX) files its financial results for the three and six months ended June 30. Find out how the company funded its five businesses while raising 86% of its capital without selling BioLargo stock.
Tags: CleantechTechnologyHealthcare ServicesSpecial Situations

Cleantech Developer Advances Five Platforms With 26% Revenue Growth

  ()
BioLargo reports 26% revenue growth excluding exited line, 54% gross margins and subsidiary-led funding model across medical, water and energy businesses.
Tags: CleantechTechnologyHealthcare ServicesSpecial Situations

Virtual Care Network Expands to Include 100,000 More New Yorkers, Reaching 24 Million Nationwide

  ()
Rocket Doctor AI Inc. (AIDR:CSE; AIRDF:OTC; 939:FRA) recently added 100,000 eligible members in New York to its network. This expansion brings the total number of individuals with potential in-network access to the company's virtual care services to approximately 10 million in New York and 24 million across the United States.
Tags: Biotechnology / PharmaceuticalsHealthcare Services

Virtual Care AI Provider Expands Potential Access to 100k+ New York Covered Lives

  ()
Rocket Doctor AI expanded potential in-network access to more than 100,000 additional eligible covered lives in New York through a new payer agreement, while continuing to expand its physician network and healthcare AI capabilities in the United States.
Tags: Biotechnology / PharmaceuticalsHealthcare ServicesArtificial Intelligence

AI Cancer Drug Developer Advances Pipeline as Funding Expands

  ()
Rakovina Therapeutics Inc. (RKV:TSX.V) is advancing in vivo testing and AI-driven lead optimization across its cancer drug pipeline as it expands relationships with AI companies and pursues additional non-dilutive funding.
Tags: Healthcare ServicesLife Sciences Tools & Diagnostics

AI Health Platform Expands Into Women's Health and Sleep With New Revenue Expected in Q4

  ()
DarioHealth Corp. (DRIO:NASDAQ) launched Dario Women and Dario Sleep, expanding its provider-backed cardiometabolic platform with programs expected to begin contributing recurring revenue in the fourth quarter.
Tags: Healthcare Services

Digital Health Provider Launches Women's Health and Sleep Solutions

  ()
DarioHealth expands its cardiometabolic platform with Dario Women and Dario Sleep programs. Revenue contribution expected late 2026 amid rising demand for multi-condition digital care solutions.
Tags: Healthcare Services

This AI Healthcare Platform Is Taking Its New York Expansion Through 2029

  ()
Rocket Doctor AI Inc. (AIDR:CSE; AIRDF:OTC; 939:FRA) extended its EngageWell partnership after an initial virtual-care pilot connected more than 400 underserved New Yorkers with physician-led care.
Tags: Healthcare ServicesLife Sciences Tools & DiagnosticsArtificial IntelligenceTechnology

NY Telehealth Extension Advances Rocket Doctor AI Platform

  ()
Rocket Doctor AI extends its New York telehealth engagement through 2029, combining grants and Medicaid to serve underserved patients while scaling its AI platform amid strong digital health market growth.
Tags: Healthcare ServicesLife Sciences Tools & DiagnosticsArtificial IntelligenceTechnology

New GLP-1 Platform Combines Doctor Prescriptions, AI Coaching and Chronic Care

  ()
DarioHealth Corp. (NASDAQ: DRIO) introduced its Integrated GLP-1 Program, bringing licensed provider evaluations, FDA-approved GLP-1 prescribing where clinically appropriate and ongoing care into one experience.
Tags: Biotechnology / PharmaceuticalsHealthcare Services

Digital Health Firm Launches Integrated GLP-1 Program

  ()
DarioHealth integrates its digital platform with licensed providers to offer end-to-end GLP-1 support. See how the new program targets employers and health plans in a growing market.
Tags: Biotechnology / PharmaceuticalsHealthcare Services

Healthcare Platform Clears Major Security Milestone After Independent Audit

  ()
Rocket Doctor AI Inc. (AIDR:CSE; AIRDF:OTC; 939:FRA) said its wholly owned Rocket Doctor platform achieved SOC 2 Type I compliance following an independent third-party audit of its security, privacy, and operational controls.
Tags: Healthcare ServicesLife Sciences Tools & Diagnostics

Digital Health Platform Achieves SOC 2 Milestone in Booming Sector

  ()
Rocket Doctor AI reaches SOC 2 Type I compliance, strengthening its enterprise position as the digital health market expands rapidly with rising AI adoption.
Tags: Healthcare ServicesLife Sciences Tools & Diagnostics

Cleantech Co. Relaunches Pet Brand Under Its Own Control

  ()
BioLargo Inc. (BLGO:OTCQX) unveils plans to reintroduce its enormously popular CupriDyne-based pet odor products to the consumer market. This time, the company says it will own the brand and do it its own way.
Tags: TechnologySpecial SituationsHealthcare ServicesLife Sciences Tools & DiagnosticsCleantech

Showing Results: 1 to 25 of 44 Next